Related Experiment Video

Updated: Mar 16, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.3K

Management of Juvenile Idiopathic Arthritis: A Clinical Guide

Štefan Blazina1, Gašper Markelj1, Mojca Zajc Avramovič1

  • 1Department of Allergology, Rheumatology and Clinical Immunology, Children's Hospital, University Medical Center Ljubljana, Bohoričeva 20, 1525, Ljubljana, Slovenia.

Paediatric Drugs
|August 4, 2016
PubMed

Insights

Juvenile idiopathic arthritis (JIA) management balances effective treatments like biologics with avoiding overtreatment. Methotrexate remains a key first-line therapy for polyarticular JIA, while biologics target refractory cases.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Juvenile idiopathic arthritis (JIA) is the most prevalent chronic rheumatic condition in childhood.
  • Biologic drugs have significantly improved JIA patient outcomes.
  • Overtreatment is a concern with early aggressive biologic use in patients who may respond to conventional therapies.

Purpose of the Study:

  • To provide a clinically oriented guide for managing JIA.
  • To focus on pharmacological treatment strategies for JIA.
  • To discuss challenges in JIA treatment, including medication choice, timing, and side effect management.

Main Methods:

  • Review of current pharmacological treatments for JIA.
  • Discussion of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids (intra-articular and systemic), disease-modifying anti-rheumatic drugs (DMARDs), and biologic agents.
  • Analysis of treatment failure, early aggressive treatment strategies, and drug tapering.

Main Results:

  • Methotrexate is the recommended first-line long-term therapy for most children with polyarticular JIA.
  • Tumor necrosis factor-α inhibitors are beneficial for refractory non-systemic JIA.
  • Interleukin-1 and interleukin-6 blockade show efficacy in systemic JIA.

Conclusions:

  • The optimal choice and timely administration of medications are crucial for achieving early and sustained JIA remission with minimal side effects.
  • This review offers practical guidance on JIA management, including alternative treatment options.
  • Addressing treatment failure and optimizing drug tapering are key considerations for physicians.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.4K

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
469
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
518
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
426
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.6K